Treatment of mindfulness-based psychotherapy in adolescent inpatients with substance use disorders

Treatment of mindfulness-based psychotherapy in adolescent inpatients with substance use disorders - IMAC-Mind it

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00014041

Enrollment

246

Registered

2018-04-17

Start date

2018-08-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F12.2 F10.2 F11.2 F13.2 F14.2 F15.2 F16.2 F17.2 F18.2 F19.2

Interventions

Group 1: Patients in the experimental group receive 12 group therapy sessions of a mindfulness-based therapy manual à 45 minutes in 8 weeks in addition to the stationary treatment as usual (TAU). The

Eligibility

Sex/Gender

All

Age

13 Years to 19 Years

Inclusion criteria

Inclusion criteria: Adolescents with substance use disorders, who completed the stationary withdrawal and want an additional stationary therapy.

Exclusion criteria

Exclusion criteria: - Acute suicidality - Schizophrenia, acute psychotic symptoms - IQ below 70 - Unsatisfactory knowledge of the German language of the patient or his/her parents

Design outcomes

Primary

Measure	Time frame
The primary outcome of the study is the number of days with substance use (alcohol, psychoactive substances and/or illicit drugs) in the last 30 days 6 months after completion of the mindfulness-based therapy tool. Drug use will be determined by the timelife-followback-interview (TLFB).	—

Secondary

Measure	Time frame
Time points of assessment: - t0: Before treatment start - t1: 4 weeks after treatment start - t2: 8 weeks after treatment start - t3: 6 months after treatment completion - Craving will be assessed by the CCS-7 [Inventory for an assessment of cannabis craving] (Schnell et al., 2011) in t0, t1, t2, t3 - Subjective experienced changes in well-being/health related life quality assessed by the KIDSCREEN-10 [Erfassung der gesundheitsbezogenen Lebensqualität von Kindern und Jugendlichen mittels Selbstauskunft und Fremdurteil] (Ravens-Sieberer et al., 2008) in t0, t2, t3 - Abstinence motivation (Körkel & Schindler, 2004) in t0, t2, t3 - Degree of substance addiction by the SDS [Severity of Dependence Scale] (Gossop et al., 1995) in t0, t2, t3 - Mindfulness-skills will be assessed with the MTASA [Mindful thinking and action scale for adolescents] (West et al., 2005) in t0, t1, t2, t3 - Impulsivity with the UPPS-scale [Impulsive behavior scale] (Kämpfe & Mitte, 2009) in t0, t2, t3 - Perceived stress with the PSS-4 [Perceived stress scale] (Klein et al., 2016) in t0, t1, t2, t3 - Number of disability days in school/work in t0, t3 - Comorbid diagnoses with the DISYPS checklists [Diagnostik-System für psychische Störungen nach ICD-10 und DSM-V für Kinder und Jugendliche] for ADHD, CD, depression, anxiety und trauma (Döpfner & Görtz-Dorten, 2017) in t0 - General level of psychosocial functioning with the GAF [Globale Beurteilung des psychosozialen Funktionsniveaus] of the ICD-10 (Remschmidt & Schmidt, 2009) in t0, t3 - Changes in medication intermittently - Adherence of the applied interventions to MBRP concepts (Chawla et al., 2010), competence of the therapists (Kohrt et al., 2015) and feasibility of the elaborated manual (Bird et al., 2014), intermittently - Treatment acceptance of the patients (participation in the group sessions, homework implementation, exercises), intermittently - Recording of all treatment modules included in TAU, intermittently	—

Measure

Time frame

Time points of assessment: - t0: Before treatment start - t1: 4 weeks after treatment start - t2: 8 weeks after treatment start - t3: 6 months after treatment completion - Craving will be assessed by the CCS-7 [Inventory for an assessment of cannabis craving] (Schnell et al., 2011) in t0, t1, t2, t3 - Subjective experienced changes in well-being/health related life quality assessed by the KIDSCREEN-10 [Erfassung der gesundheitsbezogenen Lebensqualität von Kindern und Jugendlichen mittels Selbstauskunft und Fremdurteil] (Ravens-Sieberer et al., 2008) in t0, t2, t3 - Abstinence motivation (Körkel & Schindler, 2004) in t0, t2, t3 - Degree of substance addiction by the SDS [Severity of Dependence Scale] (Gossop et al., 1995) in t0, t2, t3 - Mindfulness-skills will be assessed with the MTASA [Mindful thinking and action scale for adolescents] (West et al., 2005) in t0, t1, t2, t3 - Impulsivity with the UPPS-scale [Impulsive behavior scale] (Kämpfe & Mitte, 2009) in t0, t2, t3 - Perceived stress with the PSS-4 [Perceived stress scale] (Klein et al., 2016) in t0, t1, t2, t3 - Number of disability days in school/work in t0, t3 - Comorbid diagnoses with the DISYPS checklists [Diagnostik-System für psychische Störungen nach ICD-10 und DSM-V für Kinder und Jugendliche] for ADHD, CD, depression, anxiety und trauma (Döpfner & Görtz-Dorten, 2017) in t0 - General level of psychosocial functioning with the GAF [Globale Beurteilung des psychosozialen Funktionsniveaus] of the ICD-10 (Remschmidt & Schmidt, 2009) in t0, t3 - Changes in medication intermittently - Adherence of the applied interventions to MBRP concepts (Chawla et al., 2010), competence of the therapists (Kohrt et al., 2015) and feasibility of the elaborated manual (Bird et al., 2014), intermittently - Treatment acceptance of the patients (participation in the group sessions, homework implementation, exercises), intermittently - Recording of all treatment modules included in TAU, intermittently

—

Countries

Germany

Contacts

Public ContactLaura Mokros

LWL Universitätsklinik Hamm

laumokro@lwl.org02381 893 8052

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 4, 2026